Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 10, 2019
[Exhaustive analysis of genetic mutations associated with protein S deficiency utilizing next-generation sequencing analysis]Akito Ichiki, Hiroshi Inaba, Keiko Shinozawa, et al.
Internal Medicine (Tokyo, Japan)|April 3, 2015
Native valve endocarditis caused by Neisseria elongata Subsp. nitroreducensHanako Osuka, Akito Ichiki, Masae Yamamoto, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|August 17, 2023
Young age is a key determinant of body weight gain after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in Japanese people living with HIVRyoko Sekiya, Takashi Muramatsu, Akito Ichiki, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 21, 2019
Long-term administration of pegylated liposomal doxorubicin at almost twice the recommended lifetime dose in 10 years without cardiotoxicity in a Japanese patient with HIV-associated Kaposi sarcomaKazuhisa Yokota, Mihoko Yotsumoto, Takashi Muramatsu, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 17, 2019
[Undetectable anti-platelet factor 4/heparin antibodies with IgG-specific chemiluminescent immunoassays in a heparin-induced thrombocytopenia patient]Masato Bingo, Makoto Kaneko, Yoshiko Kamikubo, et al.
Plos One|November 20, 2025
Serology change-based clinical interpretation of indeterminate serostatus post-hepatitis B virus infection in people living with HIVEi Kinai, Mio Ishikura, Ryui Miyashita, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|October 3, 2018
[Syphilis Testing and High Rate of Infection Among HIV-infected Patients]Mika Shiotsuka, Yasuyuki Yamamoto, Mihoko Yotsumoto, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 24, 2024
Effects of switching to dolutegravir/lamivudine from tenofovir alafenamide fumarate/emtricitabine/dolutegravir or abacavir/lamivudine/dolutegravir on body weight and lipid profile in Japanese people living with HIVKenichi Ikegaya, Takashi Muramatsu, Ryoko Sekiya, et al.
Pageof 1